Volume 24, Number 4 - December 2021

Diabetic Ketoacidosis: Preventable through public awareness and early recognition

By
Dr Jason Yates

MBBS FRACP

Medical Director/Paediatric Endocrinologist, Townsville Hospital and Health Service

Jason is a paediatric endocrinologist and is the chair of the Type 1 Working Group as part of the Statewide Diabetes Clinical Network. Jason is the project lead for the Diabetes, Know the signs, Ask campaign, aimed at reducing the rate of DKA at first presentation of Type 1 Diabetes.

Introduction

Diabetic ketoacidosis (DKA) is a severe and life-threatening complication of Type 1 Diabetes (T1D).  A recent review of diabetes centres across Queensland revealed the rate of DKA at first presentation of T1D in children was 47%.1  This is unacceptably high and has increased over the last 20 years.2,3,4   Several studies have shown that most DKA presentations are preventable through early recognition of the four main symptoms of hyperglycaemia.3,5,6  Polydipsia, polyuria, weight loss and lethargy are also referred to as the 4Ts (Thirsty, Toilet, Thinner, Tired).  A recent project funded by Clinical Excellence Queensland aimed to develop an intervention strategy aimed at reducing the rate of DKA at first presentation of T1D in children.  This project is called the ‘Diabetes, Know the signs, Ask’ campaign.

The Problem

Over the past decade, there has been a steady rise in the DKA rate at first diagnosis of T1D.2,3,4  A recent review of diabetes services across Queensland revealed the rate had climbed to 47% for the state.1  There were some pockets where the rate was closer to 100%.1   A review of both national and international literature suggests the rising prevalence of DKA at first diagnosis of T1D is a worldwide problem.3,4,7,8,9  The project team investigated two main areas for intervention – primary care and community knowledge.  Several studies had highlighted the delays in diagnosis at a primary care level due to either misdiagnosis of a more common childhood illness or lack of recognition of any of the signs and symptoms.10,11,12  The Queensland GP liaison officer (GPLO) network, the Royal Australasian College of General Practitioners (RACGP) and primary care networks (PHN) were important collaborators to help understand the drivers for delays in diagnosis and design solutions.  

Unfortunately, there were no published reports of community knowledge of the signs and symptoms of hyperglycaemia and so the project team surveyed 100 random anonymous parents through Playgroups Queensland.(Figure 1)  The survey asked parents to choose four symptoms from a list of eleven that they would seek urgent medical attention for.  The results revealed a low level of concern for the most common of the 4Ts – Thirsty and Toilet.14 Overall, the project team concluded that there was a low level of community knowledge of the 4Ts and low index of suspicion for diabetes in children at a primary care level.

Figure 1: Playgroups Queensland Survey results.14 

Further reviews of the literature targeted previously trialed interventions aimed at lowering DKA rates at first diagnosis. Those interventions which targeted at early recognition of the signs and symptoms of hyperglycaemia were most effective at reducing the DKA rates.3,5,6  Reductions of 50% or more were seen in some of these interventions which have highlighted the preventable nature of DKA at first diagnosis of T1D.3,5,6

The Why

There are compelling reasons for reducing the rate of DKA at first presentation of T1D. These reasons can be broken down into three key parts – short, medium- and long-term consequences of DKA at diagnosis.  In the short-term, the overall mortality rate of DKA in children is less than 1%.15 Cerebral oedema is a significant and severe complication of DKA and has far worse outcomes for affected children.16,17  The mortality rate for cerebral oedema is up to 35%, however neurological morbidity in this cohort is as high as 40%.17  Other short-term impacts include increased hospital length of stay, trauma for both child and family and iatrogenic complications such as venous thrombosis from central venous catheter insertion.  In this age of dwindling health budgets, an increased cost of high dependency as compared to the general ward environment must also be considered.

In the medium term, there is evolving research in neurocognitive outcomes for children presenting in DKA at first diagnosis of T1D.  Studies have indicated a reduction in neurocognitive function out to 4-6 months from diagnosis independent of glycaemic management for those presenting in DKA at first diagnosis.18,19 More research in this space is required to understand whether this decline is temporary or permanent.

In the long-term, there is robust evidence to suggest that DKA at first diagnosis leads to poorer outcomes and increased complication rates than non DKA peers.20,21 

The Solution

A co-design methodology was utilised to design solutions that could target both primary care clinicians and community members.  A collaborative multi-disciplinary stakeholder group was consulted at all stages of the solution design. Consumers were engaged at the start with respect both to understanding the barriers to early diagnosis and the likely successful intervention strategies. The unexpected outcome was that due to this co-design process, the project was able to be implemented at no additional cost due to the widespread commitment of the stakeholder group. As stated, the GPLO networks and PHN were instrumental in designing the messaging for primary care clinicians and the mode to deliver it. Health pathways in a web-based platform used in Queensland for GPs to streamline referrals, ensuring the correct investigations have been undertaken to allow for expedited review with the correct specialist.  

The diabetes health pathway was updated to be simple and clear on the signs and symptoms of hyperglycaemia and the requirement for point of care finger prick blood glucose testing as the only test necessary.  Other diagnosis pages commonly associated with misdiagnosis such as urinary tract infection and gastroenteritis were updated with red flags to consider hyperglycaemia.  In collaboration with the RACGP, a clinical guideline was written for the early recognition of hyperglycaemia in childrenthis is published on the Clinical Excellence Queensland website.22   The child health manual was updated with key information for child health nurses on when to consider hyperglycaemia in the children they review.

Campaign posters and magnets were designed after consumer consultation.  One was designed for clinicians and highlighted the 4Ts with the need for finger prick testing.  Another was consumer-facing, highlighting the importance of early medical review for any of the 4T signs. 

Most Queensland Health Hospitals and Health Services displayed the social media campaign materials on world Diabetes Day (November 14th 2020), as did key organisations such as Diabetes Australia and JDRF.

Multiple community groups were engaged in the co-design process and were instrumental in the implementation. Playgroups Queensland shared the materials through social media and web-based platforms and were instrumental in the survey of community knowledge. The education sector was well represented through Queensland Department of Education, Queensland Catholic Education and Independent Schools Queensland.  They distributed the campaign material in local schools, tea rooms and through newsletters to increase community awareness of the 4Ts. Lions club Australia and Queensland Country Women’s Association also shared campaign materials in local club houses and on social media.

Evaluation of the success of the campaign is currently underway, although a lack of centralised data in Queensland has become the burden of tracking DKA rates. Anecdotally, members of Queensland Department of Education noted the success of the posters. There were some case stories of early diagnosis due to the prompt recognition from the teachers after seeing the posters placed in tea rooms and offices.   Once outcomes are confirmed and collated, an update will be provided to all stakeholders.  The recently released Australian National Diabetes Strategy 2021-2030 has highlighted early recognition of Type 1 Diabetes as goal 2 in the strategy.23  The Diabetes, Know the signs, Ask campaign was designed to be rolled out widely and ongoing partnership with key stakeholders will be important to achieving this goal.

Conclusion

The rate of DKA at first diagnosis of T1D is unacceptably high.  Based on the literature, a significant percentage of DKA presentations are preventable through community education and early primary care recognition of the signs and symptoms of hyperglycaemia.5,6  There are short, medium- and long-term implications of DKA for children living with diabetes.15-21  The ‘Diabetes, Know the signs, Ask’ campaign designed a suite of campaign resources including posters/magnets, clinical guidelines, health pathways and social media tiles aimed at increasing the level of awareness of the signs and symptoms of hyperglycaemia known as the 4Ts – Thirsty, Toilet, Thinner, Tired.  Early recognition of these signs should lead to immediate medical review, point of care finger prick blood glucose test and timely diagnosis and definitive.

Diabetes educators have a vital role in both advocacy and leadership in both their work setting and the wider community.  There are several ways that diabetes educators can become involved in this work.  Raising awareness of the 4Ts through parent groups, school-based health nurses and communication with primary care practice nurses will help spread the important message of early recognition.  

Acknowledgements

Playgroups Queensland

Queensland Education, Queensland Catholic Education, Independent Schools Queensland

Lions Australia

Queensland Country Women’s Association

The Pharmacy Guild of Australia

Diabetes Australia

JDRF

ADEA

APEG

References

1.

Wales J, Yates J. Peer review of rural and tertiary Queensland paediatric diabetes services: a pilot project from the National Health Service. J Paediatric Child Health 2019;55:701–706.

2.

Harris M, et al. Consistently high incidence of diabetic ketoacidosis in children with newly diagnosed type 1 diabetes. Letter to MJA 2013 Aug 19:242.

3.

Patwardhan R, et al. Diabetic ketoacidosis incidence in children at first presentation of type 1 diabetes at an Australian regional hospital: the effect of health professional education. Pediatric Diabetes 2018;1–7.

4.

Jacobs S et al. Diabetic ketoacidosis in children with newly diagnosed type 1 diabetes. Unpublished work by Jacobs S, Harris M, Johnson S; 2020.

5.

Vanelli M, et al. Campaign for diabetic ketoacidosis prevention still effective 8 years later. Diabetes Care 2007 April;30(4):e12.

6.

King BR, et al. A diabetes awareness campaign prevents diabetic ketoacidosis in children at their initial presentation with type 1 diabetes. Pediatric Diabetes 2012;13:647–651.

 

7.

Cherubini V, et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. Diabetologia 2020. doi:10.1007/s00125-020-05152-1

8.

Jefferies C, et al. 15-year incidence of diabetic ketoacidosis at onset of type 1 diabetes in children from a regional setting (Auckland, New Zealand). Sci Rep 2015;5:10358. doi:10.1038/screp1-358

9.

Lansdown AJ, et al. Prevalence of ketoacidosis at diagnosis of childhood onset type 1 diabetes in Wales from 1991–2009 and effect of a publicity campaign. Diabetic Medicine 2012 Mar; 29:1506–1509.

10.

Pawlowicz M, et al. Difficulties of mistakes in diagnosing type 1 diabetes in children: demographic factors influencing delayed diagnosis. Pediatric Diabetes 2009;10:542–549.

11.

Biu H, et al. Is diabetic ketoacidosis at disease onset a result of missed diagnosis? J Pediatrics 2010;156:472–7.

12.

Usher-Smith JA, et al. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia 2012;55:2878–2894.

13.

Usher-Smith J, et al. ‘Looking for the needle in the haystack’: a qualitative study of the pathway to diagnosis of type1 diabetes in children. BMJ Open 2013,3:e004068.

14.

Buckley B et al. Exploring parents’ knowledge of prodromal high blood glucose symptoms prior to the diagnosis of type 1 diabetes in children. Journal of Children and Young People’s Health 2020; 1(1):28-34

15.

Onyiriuka A.N., et all. Ketoacidosis at diagnosis of type 1 diabetes in children and adolescents: frequency and clinical characteristics. J Diabetes Metab Disord 2013; 12:47

16.

Glaser NS. et al.  Mechanism of cerebral edema in children with diabetes ketoacidosis.  J Pediatr. 2004 Aug; 145(2);164-71

17.

Glaser N., Barnett P., McCaslin I., et. al.: Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med 2001; 344:264-269

18.

Cameron FJ. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care 2014;37:1554–1562.

19.

Jessup, et al. Effect of diabetic ketoacidosis on visual and verbal neurocognitive function in young patients presenting with new-onset type 1 diabetes.  J Clin Res Pediatr Endocrinol, 2015 Sep;7(3):203-10

20.

Shalitin S, et al. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control. Pediatr Diabetes 2018;19:320–328. doi:10.1111/pedi.12546

21.

Nathan. The diabetes control and complication trial / epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 2014 Jan;37(1):9–16.

22.

https://clinicalexcellence.qld.gov.au/resources/diabetes-resources/diabetic-ketoacidosis

23.

Australian National Diabetes Strategy 2021-2030, Department of Health, Australian Government

Discussion

There are currently no comments.

Other Articles in this Edition